Skip to content

Farmax

Active Private limited companyfounded 2012active for 14 yearsVlasbloemstraat 17, 8790 WaregemKBO/BCE: BE 0843.399.855

Lifetime

14 annual accounts with figures on one time axis
peak of €54,617 in 2025
€54,617▲ 119%
lowest -€7,158 in 2019
€53,833▲ 256%
peak of €155,654 in 2025
€155,654▲ 52.9%
€92,709▲ 241%
Board1 name since 2023
1 director
Documentsfilings and deeds
29-09-202660 days late
2025micro format
Gross margin from €24,980 to €54,617Result from €15,116 to €53,833Equity from €101,821 to €155,654Debts from €27,170 to €92,709Cash from €9,690 to €16,504

Key points

from the 2025 annual accounts

Equity

€155,654 ▲ 52.9%
€102,0002024€156,0002025

Equity rose in 2025 from €101,821 to €155,654.

Turnover

≈ €250,000 estimated

The micro format states no turnover.

Debts

€92,709 ▲ 241%
Suppliers
+36,494
Taxes and wages
+29,045

Debts rose by €65,540 in 2025.

Liquidity

2.63 was 4.57 in 2024

Short-term debts rose from €27,170 to €92,709.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

Six of the last ten came late. The 2021 accounts came in latest, 60 days after the end of the period.

Position in the sector

€53,833

Higher net result than 86% of companies in wholesale trade. The sector median is €5,117, over 15,511 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,728 companies had the same profile as Farmax has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,728 companies, not a prediction for Farmax. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 07-02-2012
  • founderdeed of 07-02-2012
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0843399855
changes role from manager to director Discharge granted to · General meeting of 01-12-2023 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €6,200 paid up · Founded by and · appointed as manager · published on 07-02-2012 · Gazette deed
First establishment Vlasbloemstraat 17, Waregem
All 25 events

Comparable companies

same main activity, similar in size and age
Company
Farmax Waregem €248,363 €54,617 62.7% -
LOADPROTECT Roeselare €259,210 €53,253 76.8% -
MUST VISITS Koksijde €199,701 €56,520 60.4% -
SWEPA Bree €239,310 €55,673 54.3% -
VAN DE VOORDE ELS Waasmunster €267,065 €53,537 66.9% -
AX CONCEPT IMMO Honnelles €269,278 €51,219 56.2% -
Track & Sell Overijse €263,733 €48,124 92.6% -

These companies have the same main activity as Farmax: agents specialised in the wholesale of other particular products (NACE 46180). They are comparable in size and age: total assets between €200,000 and €269,000, founded between 2010 and 2012.

Official details

Source: KBO
Status
Active since 06-02-2012Normal situation
Activity
Agents specialised in the wholesale of other particular productsNACE 46180and 1 other
Establishment unit
2.206.710.3098790 Waregem, since 06-02-2012
Financial year end
31 December
Peppol
Reachable since 10-10-2025
Company details

Annual accounts 2025

€248,363▲ 92.5%
Filing
Filed on 29-09-2026
Financials

Insights on Farmax

Farmax files the micro format. That format states no turnover. The gross margin rose from €23,612 in 2012 to €54,617 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Farmax

What is the company number of Farmax?
The company number of Farmax is 0843.399.855. The VAT number is the same number with BE in front: BE 0843.399.855.
Where is Farmax based?
The registered office is at Vlasbloemstraat 17, 8790 Waregem.Company details
What does Farmax do?
According to the KBO register, the main activity is agents specialised in the wholesale of other particular products (NACE 46180).
What is the legal form of Farmax?
Farmax is a private limited company (BV).
When was Farmax founded?
Farmax was founded on 06-02-2012.
Is Farmax still active?
Yes, Farmax is an active enterprise in the KBO register.
What is the turnover of Farmax?
The turnover in financial year 2025 is about €250,000. This figure is estimated from the gross margin of €54,617 and 30 comparable companies (NACE 461). It probably lies between €130,000 and €590,000.Financials
Is Farmax profitable?
In financial year 2025, Farmax made a profit of €53,833.
Where can I find the annual accounts of Farmax?
Farmax filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Farmax due?
Farmax must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.